Literature DB >> 21480477

A comprehensive description of the severity groups in Cockayne syndrome.

Valerie Natale1.   

Abstract

Cockayne syndrome (CS) is a rare degenerative disorder with a common set of symptoms but a very wide variation in phenotype. The variation is sufficiently wide that CS patients have traditionally been described in three different severity groups. Unfortunately, there is no single source for information about the different severity groups. This problem can complicate not only diagnosis, but accurate prognosis as well. The goal of this study was to describe the phenotypic variation in CS as completely as possible. This article provides extensive descriptions of traits common to each group and their degree of severity in each group. Forty-five people with CS were surveyed and information from the published literature was used to increase the sample sizes for calculations. This study provides new information, including statistical data for each of the three severity groups (mean age at death, average head circumference, and average length or stature). The study includes cerebro-oculo-facial syndrome (COFS) as a severe form of CS, based on results of recently published genetic studies performed by other authors. This study proposes revised names for CS severity groups: severe, moderate, and mild. The groups were formerly called Type II/early onset CS, Type I/classical CS, and Type III/atypical/mild/late-onset CS, respectively. A fourth newly documented group, UV sensitivity only/adult onset, is also described. Average ages of death were calculated as 5.0 years (severe), 16.1 years (moderate), and 30.3 years (mild).
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21480477     DOI: 10.1002/ajmg.a.33933

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  45 in total

1.  Cockayne syndrome, underlying molecular defects and p53.

Authors:  Brian R Berquist; Vilhelm A Bohr
Journal:  Cell Cycle       Date:  2011-12-01       Impact factor: 4.534

Review 2.  Mitochondrial deficiency in Cockayne syndrome.

Authors:  Morten Scheibye-Knudsen; Deborah L Croteau; Vilhelm A Bohr
Journal:  Mech Ageing Dev       Date:  2013-02-19       Impact factor: 5.432

Review 3.  DNA repair mechanisms in dividing and non-dividing cells.

Authors:  Teruaki Iyama; David M Wilson
Journal:  DNA Repair (Amst)       Date:  2013-05-16

4.  Cockayne syndrome-derived neurons display reduced synapse density and altered neural network synchrony.

Authors:  Alexandre T Vessoni; Roberto H Herai; Jerome V Karpiak; Angelica M S Leal; Cleber A Trujillo; Annabel Quinet; Lucymara F Agnez Lima; Carlos F M Menck; Alysson R Muotri
Journal:  Hum Mol Genet       Date:  2016-01-10       Impact factor: 6.150

Review 5.  Cockayne syndrome: Clinical features, model systems and pathways.

Authors:  Ajoy C Karikkineth; Morten Scheibye-Knudsen; Elayne Fivenson; Deborah L Croteau; Vilhelm A Bohr
Journal:  Ageing Res Rev       Date:  2016-08-06       Impact factor: 10.895

Review 6.  DNA Damage, DNA Repair, Aging, and Neurodegeneration.

Authors:  Scott Maynard; Evandro Fei Fang; Morten Scheibye-Knudsen; Deborah L Croteau; Vilhelm A Bohr
Journal:  Cold Spring Harb Perspect Med       Date:  2015-09-18       Impact factor: 6.915

Review 7.  DNA Damage and Associated DNA Repair Defects in Disease and Premature Aging.

Authors:  Vinod Tiwari; David M Wilson
Journal:  Am J Hum Genet       Date:  2019-08-01       Impact factor: 11.025

8.  Special issue on the segmental progeria Cockayne syndrome.

Authors:  David M Wilson; Vilhelm A Bohr
Journal:  Mech Ageing Dev       Date:  2013-04-11       Impact factor: 5.432

9.  Elements That Regulate the DNA Damage Response of Proteins Defective in Cockayne Syndrome.

Authors:  Teruaki Iyama; David M Wilson
Journal:  J Mol Biol       Date:  2015-11-23       Impact factor: 5.469

Review 10.  Dysregulation of RNA polymerase I transcription during disease.

Authors:  K M Hannan; E Sanij; L I Rothblum; R D Hannan; R B Pearson
Journal:  Biochim Biophys Acta       Date:  2012-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.